2,3-Di-substituted N-heteroaromatic propionamides with said substitution at the 3-position being a substituted phenyl group and at the 2-position being a methyl cycloalkyl ring, said propionamides being glucokinase activators which increase insulin secretion in the treatment of type II diabetes.

propionamides de 2,3-Di-substituted N-heteroaromatic com substituição dita no 3-position que é um grupo phenyl substituído e no 2-position que é um anel methyl do cycloalkyl, propionamides ditos que são activadores do glucokinase que aumentam o secretion do insulin no tratamento do tipo diabetes de II.